- Home
- RYI vs ORGO Comparison
RYI vs ORGO Comparison
Compare RYI & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYI
- ORGO
- Stock Information
- Founded
- RYI 1842
- ORGO 1985
- Country
- RYI United States
- ORGO United States
- Employees
- RYI N/A
- ORGO N/A
- Industry
- RYI Metal Fabrications
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- RYI Industrials
- ORGO Health Care
- Exchange
- RYI Nasdaq
- ORGO Nasdaq
- Market Cap
- RYI 700.7M
- ORGO 665.8M
- IPO Year
- RYI N/A
- ORGO N/A
- Fundamental
- Price
- RYI $23.07
- ORGO $4.45
- Analyst Decision
- RYI Hold
- ORGO Buy
- Analyst Count
- RYI 1
- ORGO 2
- Target Price
- RYI $25.00
- ORGO $5.50
- AVG Volume (30 Days)
- RYI 213.3K
- ORGO 1.4M
- Earning Date
- RYI 04-30-2025
- ORGO 05-08-2025
- Dividend Yield
- RYI 3.29%
- ORGO N/A
- EPS Growth
- RYI N/A
- ORGO N/A
- EPS
- RYI N/A
- ORGO N/A
- Revenue
- RYI $4,598,700,000.00
- ORGO $482,043,000.00
- Revenue This Year
- RYI $6.73
- ORGO $3.31
- Revenue Next Year
- RYI $2.36
- ORGO $12.50
- P/E Ratio
- RYI N/A
- ORGO N/A
- Revenue Growth
- RYI N/A
- ORGO 11.29
- 52 Week Low
- RYI $17.18
- ORGO $2.17
- 52 Week High
- RYI $33.06
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- RYI 53.93
- ORGO 52.57
- Support Level
- RYI $21.39
- ORGO $4.11
- Resistance Level
- RYI $22.25
- ORGO $4.38
- Average True Range (ATR)
- RYI 1.40
- ORGO 0.35
- MACD
- RYI 0.13
- ORGO 0.03
- Stochastic Oscillator
- RYI 80.76
- ORGO 80.17
About RYI Ryerson Holding Corporation
Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. Its customers range from local, independently owned fabricators and machine shops to large, international original equipment manufacturers. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company generates substantially all of its revenue from sales of metal products. Geographically, the majority revenue is generated from the United States.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.